Kintara Therapeutics Stock Quote KTRA - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

0.1513

Bid

0.1503

Ask

0.1514

Volume

3,043,583

0.1499 Day's Range 0.1624

0.081 52 Week Range 5.98

Market Cap

5.856M

Previous Close

0.1572

Open

0.1565

Last Trade

0.1513

Last Trade Time

Financial Volume

$ 479,854

VWAP

0.157661

Average Volume (3m)

15,331,465

Shares Outstanding

39,037,899

Dividend Yield

PE Ratio

-0.39

Earnings Per Share (EPS)

-0.38

Revenue

Net Profit

-15.02M

Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and ... Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and REM-001 for CMBC. VAL-083 is a small-molecule chemotherapeutic with a novel mechanism of action that has demonstrated clinical activity against a range of cancers, including the central nervous system, ovarian, and other solid tumors. The company is also advancing its proprietary late stage photodynamic therapy (PDT) platform that holds promise as a localized cutaneous or visceral tumor treatment as well as in other potential indications. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.kintara.com

Headquarters

Reno, Nevada, USA

Founded

1970

Kintara Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KTRA. The last closing price for Kintara Therapeutics was $0.16. Over the last year, Kintara Therapeutics shares have traded in a share price range of $ 0.081 to $ 5.98.

Kintara Therapeutics currently has 39,037,899 shares outstanding. The market capitalization of Kintara Therapeutics is $5.86 million. Kintara Therapeutics has a price to earnings ratio (PE ratio) of -0.39.

Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer

Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer PR Newswire SAN DIEGO, Feb. 12, 2024 - 15-patient Open Label Study to...

Form 8-K - Current report

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0437	-22.4102564103	0.195	0.195	0.1356	14109414	0.15135383	CS
4	0.0233	18.203125	0.128	0.195	0.101	7403436	0.14072904	CS
12	0.0312	25.9783513739	0.1201	0.24	0.081	15331465	0.12757041	CS
26	-0.2804	-64.9525133194	0.4317	0.678	0.081	10453986	0.14232781	CS
52	-2.7387	-94.7647058824	2.89	5.98	0.081	5258805	0.18221152	CS
156	-69.8487	-99.7838571429	70	142.5	0.081	2794079	10.04354264	CS
260	-60.3487	-99.7499173554	60.5	167.5	0.081	2383071	14.44053833	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BENFBeneficient	$ 6.8001 (254.17%)	31.01M
SGBXSafe and Green Holdings Corporation	$ 5.49 (87.37%)	92.18M
SHOTWSafety Shot Inc	$ 0.45 (45.16%)	644
AIPArteris Inc	$ 8.185 (38.03%)	1.11M
RGFReal Good Food Company Inc	$ 0.85 (37.32%)	4.26M
MNDRMobile health Network Solutions	$ 3.33 (-84.91%)	18.76M
NUVOHoldco Nuvo Group DG Ltd	$ 2.00 (-57.54%)	1.04M
SPTSprout Social Inc	$ 28.82 (-40.15%)	13.47M
UNITUniti Group Inc	$ 4.441 (-26.35%)	21.07M
IPDNProfessional Diversity Network Inc	$ 1.29 (-24.12%)	662.59k
AAPLApple Inc	$ 183.38 (5.98%)	163.22M
SQQQProShares UltraPro Short QQQ	$ 11.08 (-5.94%)	154.59M
JAGXJaguar Health Inc	$ 0.3164 (7.91%)	142.47M
NKLANikola Corporation	$ 0.6526 (6.55%)	106.88M
SGBXSafe and Green Holdings Corporation	$ 5.49 (87.37%)	92.18M